| No images? Click here  Tuesday, 17 September 2024 MEDIA ADVISORY WHO EPI-WIN Webinar: Treatment and medical support for patients with mpox, and their families WHEN: Wednesday, 18 September 2024 at 13:00–14:15 CEST (Geneva time) WHERE: Register here CONTEXT The global mpox outbreak, which began in 2022, has resulted in over 100,000 confirmed cases reported to the WHO. The rapid spread of the new Clade 1B strain, particularly in eastern DRC and neighbouring countries and its recent detection in Sweden and Thailand, underscores the growing threat. This escalating situation led to the declaration of a Public Health Emergency of International Concern on 14 August 2024. WHO in partnership with international and regional organisations is leading the global response by providing strategic leadership, including through providing clinical expertise to improve supportive care both in hospitals and at home; developing and updating response guidance for the control of Mpox that includes infection prevention control measures, how to screen, triage and isolate patients and how to manage mild and complicated Mpox including skin lesions, complications with eyes, pain, good nutrition and hydration. The purpose of the webinar is to provide a rapid overview of the Mpox situation and to give practical guidance on treatment of mild and severe patients based on the WHO Interim guidelines developed in 2022. This includes guidance in the African context – where recognition of the Mpox rash and home care can be challenging. SPEAKERS Dr Maria D. Van Kerkhove, Director (a.i), Department of Epidemic and Pandemic Preparedness and Prevention, WHO Prof. Lucille Blumberg, ID Consultant ,medical microbiologist, South Africa Dr Andy Bulabula, CDC Ethiopia Dr Steve Woolley, Liverpool School of Tropical Medicine, UK Dr Nerissa Moodley, Dermatologist, South Africa Dr Steve Yeh, Opthalmologist, UNMC, USA  Media contact:  You are receiving this NO-REPLY email because you are included on a WHO mail list.  |
0 Comments